Modern dilemma in the therapy of the schizophrenia: neurocognition and social cognition

Abstract

Recent research data make it evident that the last generations of antypsychotics being successful in elimination of the positive psychotic symptoms still seem to be incapable to sufficiently lower exacerbation frequency and to improve social functioning. The primary reason for that is considered to be an insufficient response of the patients’ cognitive deficit to the action of antipsychotics. The importance to differentiate between neurocognition and social cognition in view of the schizophrenia treatment general strategy optimization is discussed.